| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/29/2000 | US6110695 Detecting modulators of chemotaxis between lymphocyte attractant and burkitt's lymphoma receptor polypeptide; incubating a cell with attractant and modulator, detecting binding, calcium mobility or chemotaxis, compare to reference |
| 08/29/2000 | US6110694 Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules |
| 08/29/2000 | US6110693 Methods of assaying receptor activity and constructs useful in such methods |
| 08/29/2000 | US6110691 Polypeptide associated with apoptosis; for the detection of modulators of apoptosis |
| 08/29/2000 | US6110690 SODD-specific antibodies and methods |
| 08/29/2000 | US6110688 Separating compounds from human urine; freezing human urine, thawing urine, separating precipitate by centrifuging, recovering precipitate, dissolvingin solution, dialysis, separating supernatant, isolate protein, detect with antibody |
| 08/29/2000 | US6110686 DNA hybridizing to a human cystatin-like protein (CSTIN) |
| 08/29/2000 | US6110685 Polynucleotide sequence coding translational activation polypeptide; for prevention of infecttion; bactericides; microbicides |
| 08/29/2000 | US6110681 Primers and probes for the amplification, detection and typing of Mycoplasma pneumoniae |
| 08/29/2000 | US6110675 Reagents and methods useful for detecting diseases of the prostate |
| 08/29/2000 | US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/29/2000 | US6110668 Gene synthesis method |
| 08/29/2000 | US6110666 Detection of regulatory sequences; transforming a cell with a genetically engineered expression vector, monitor preferential gene expression in cell |
| 08/29/2000 | US6110663 Methods for detecting, titering, and determining susceptibility to papillomavirus |
| 08/29/2000 | US6110590 Hexafluoroisopropanol, electrospinning, no acid treatment |
| 08/29/2000 | US6110487 Method of making porous keratin scaffolds and products of same |
| 08/29/2000 | US6110470 Dna molecules with encoded polypeptides with amino acid sequences |
| 08/29/2000 | US6110469 Hybrid plasmid for 38 kDa antigen of M. tuberculosis |
| 08/29/2000 | US6110467 Isolated porcine respiratory and reproductive virus, vaccines and methods of protecting a pig against a disease caused by a porcine respiratory and reproductive virus |
| 08/29/2000 | US6110466 Modified plant viruses as vectors |
| 08/29/2000 | US6110465 Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines |
| 08/29/2000 | US6110464 Polypeptides with amino acid sequences |
| 08/29/2000 | US6110463 Anti-Cryptosporidium parvum preparations |
| 08/29/2000 | US6110460 Methods of using morphogen analogs |
| 08/29/2000 | US6110457 Single stranded rna hybrid virus |
| 08/29/2000 | CA2034487C Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
| 08/29/2000 | CA2015687C Human serum albomin fusion polypeptide |
| 08/29/2000 | CA2010275C Pancreatic islet cell antigens obtained by molecular cloning |
| 08/29/2000 | CA1341090C Vampire bat plasminogen activators |
| 08/26/2000 | CA2296792A1 Expressed sequence tags and encoded human proteins |
| 08/25/2000 | CA2300692A1 Sequence-determined dna fragments and corresponding polypeptides encoded thereby |
| 08/24/2000 | WO2000049416A2 Receptor assay for detecting an effect test compounds have on a particular membrane receptor |
| 08/24/2000 | WO2000049170A1 MURINE 11cby RECEPTOR |
| 08/24/2000 | WO2000049167A1 Latency-associated regulatory region from herpesvirus saimiri (hvs) |
| 08/24/2000 | WO2000049163A1 Production of heterologous polypeptides from freshwater caulobacter |
| 08/24/2000 | WO2000049162A2 Compositions and methods for non-targeted activation of endogenous genes |
| 08/24/2000 | WO2000049159A1 Collagen-binding physiologically active polypeptide |
| 08/24/2000 | WO2000049152A1 Nucleic acids that code for a nucleobase transporter |
| 08/24/2000 | WO2000049151A2 POLYMORPHIC HUMAN GABAA RECEPTOR α-6 SUBUNIT |
| 08/24/2000 | WO2000049150A1 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 08/24/2000 | WO2000049149A1 Novel tnf receptor-like proteins |
| 08/24/2000 | WO2000049148A1 Novel cytokine recfptor-like protein |
| 08/24/2000 | WO2000049147A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | WO2000049146A1 Malaria vaccine |
| 08/24/2000 | WO2000049145A2 Hematopoietic genes hzf and hhl and polypeptides encoded thereof |
| 08/24/2000 | WO2000049144A2 Pyk2 binding proteins |
| 08/24/2000 | WO2000049134A1 Secreted proteins and polynucleotides encoding them |
| 08/24/2000 | WO2000049132A2 Uses of transgenic animals containing a type x collagen mutant |
| 08/24/2000 | WO2000049051A1 Human adenosine a2b anti-receptor polyclonal antibodies |
| 08/24/2000 | WO2000049049A1 An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid |
| 08/24/2000 | WO2000049048A1 Ndae1 - a new bicarbonate transporter |
| 08/24/2000 | WO2000049047A1 METHOD FOR PRODUCING A vWF PREPARATION |
| 08/24/2000 | WO2000049046A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/24/2000 | WO2000049045A1 Peptide variants of the tumour marker muc1 and the use thereof |
| 08/24/2000 | WO2000049044A1 Expression of helicobacter polypeptides in pichia pastoris |
| 08/24/2000 | WO2000049043A2 Human lipid-associated proteins |
| 08/24/2000 | WO2000049042A1 nadE |
| 08/24/2000 | WO2000049041A1 Protein preparations |
| 08/24/2000 | WO2000049040A2 Antimicrobial/endotoxin neutralizing polypeptide |
| 08/24/2000 | WO2000049039A2 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 08/24/2000 | WO2000049038A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 08/24/2000 | WO2000049034A1 Naked cuticle genes and their uses |
| 08/24/2000 | WO2000049033A1 yybQ |
| 08/24/2000 | WO2000048638A2 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | WO2000048633A1 Antibodies against hydrophobic proteins that are protective against candidiasis |
| 08/24/2000 | WO2000048631A2 Adjuvant and cell maturation agent |
| 08/24/2000 | WO2000048629A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 08/24/2000 | WO2000048628A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | WO2000048627A1 Inhibitors of separin, method for identifying them and uses |
| 08/24/2000 | WO2000048625A2 Inhibitors for use in hemostasis and immune function |
| 08/24/2000 | WO2000048622A2 Method for inhibiting inflammatory responses |
| 08/24/2000 | WO2000048621A2 Methods and compositions for regulating protein-protein interactions |
| 08/24/2000 | WO2000048620A1 Yeast cell wall peptides and antibodies thereto |
| 08/24/2000 | WO2000048558A1 Modified calycins |
| 08/24/2000 | WO2000032039A8 PURIFIED AND ISOLATED piwi FAMILY GENES AND GENE PRODUCTS AND METHODS EMPLOYING SAME |
| 08/24/2000 | WO2000031126A3 Suppression of xenotransplant rejection |
| 08/24/2000 | WO2000023469A3 Fragments of insulin-like growth factor binding protein and insulin-like growth factor, and uses thereof |
| 08/24/2000 | WO2000022134A3 Test kit for diagnosis of borrelia infection and novel borrelia antigens for the development of vaccines |
| 08/24/2000 | WO2000022112A9 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/24/2000 | WO2000021987A9 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 08/24/2000 | WO2000021569A3 Macromolecular active substance conjugates and a method for the production thereof |
| 08/24/2000 | WO2000020566A9 Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto |
| 08/24/2000 | WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use |
| 08/24/2000 | WO2000020018A9 Kappa-a conopeptides and uses therefor |
| 08/24/2000 | WO2000018922A8 Human carbohydrate-associated proteins |
| 08/24/2000 | WO2000018917A9 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION |
| 08/24/2000 | WO2000018440A8 Somatostatin receptor radioligand with increased uptake |
| 08/24/2000 | WO2000017365A3 Binary viral expression system in plants |
| 08/24/2000 | WO2000016800A9 Methods of treating chronic pain |
| 08/24/2000 | WO2000015797A3 Compositions and methods for the treatment of immune related diseases |
| 08/24/2000 | WO2000015796A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/24/2000 | WO2000015772A9 Recombinant protein production in urine |
| 08/24/2000 | WO2000015660A9 Target of rnaiii activating protein (trap) |
| 08/24/2000 | WO2000015246A9 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/24/2000 | WO2000012685A3 Genes associated with neurotransmitter processing |
| 08/24/2000 | WO1999057280A3 Neisseria meningitidis antigens and compositions |
| 08/24/2000 | WO1999046371A3 Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 08/24/2000 | WO1999042828A3 Treating cancer |
| 08/24/2000 | WO1999040938A3 Vaccines comprising interleukin-12 and herpes simplex viral antigen |
| 08/24/2000 | WO1998024898A3 Therapeutic composition comprising the kal protein and use of the kal protein |